North Rock Partners, LLC Bio N Tech Se Call Options Transaction History
North Rock Partners, LLC
- $1.14 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$884 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$481 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$464 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$202 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$192 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...